These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Schwartz LM, Woloshin S, Welch HG. Ann Intern Med; 2009 Apr 21; 150(8):516-27. PubMed ID: 19221371 [Abstract] [Full Text] [Related]
29. Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence. Im H, Huh J. Res Social Adm Pharm; 2022 Jul 21; 18(7):3119-3130. PubMed ID: 34454872 [Abstract] [Full Text] [Related]
31. Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role? Waxman HA. Health Aff (Millwood); 2004 Jul 21; Suppl Web Exclusives():W4-256-8. PubMed ID: 15452002 [Abstract] [Full Text] [Related]
32. Direct marketing of pharmaceuticals to consumers. Lyles A. Annu Rev Public Health; 2002 Jul 21; 23():73-91. PubMed ID: 11910055 [Abstract] [Full Text] [Related]
38. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Frosch DL, Krueger PM, Hornik RC, Cronholm PF, Barg FK. Ann Fam Med; 2007 Jul 21; 5(1):6-13. PubMed ID: 17261859 [Abstract] [Full Text] [Related]
39. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads. Aikin KJ, Betts KR, Boudewyns V, Johnson M, Davis CN. Res Social Adm Pharm; 2020 Sep 21; 16(9):1237-1247. PubMed ID: 31838056 [Abstract] [Full Text] [Related]